Conducted communication in a medical device system
US-2017173346-A1 · Jun 22, 2017 · US
US11235162B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11235162-B2 |
| Application number | US-201816204505-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 29, 2018 |
| Priority date | Nov 29, 2017 |
| Publication date | Feb 1, 2022 |
| Grant date | Feb 1, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A system, such as an IMD system, includes a tissue conductance communication (TCC) transmitter configured to generate a beacon signal by generating a carrier signal and modulating a first property of the carrier signal according to a first type of modulation. The TCC transmitter is configured to generate a data signal subsequent to the beacon signal by generating the carrier signal and modulating a second property of the carrier signal different than the first property according to a second type of modulation different than the first type of modulation.
Opening claim text (preview).
What is claimed is: 1. A device comprising: a housing; a tissue conduction communication (TCC) transmitter enclosed by the housing and configured to: generate a TCC carrier signal having a carrier frequency; generate at least one TCC beacon signal by modulating a first property of the TCC carrier signal according to a first type of modulation by: modulating the carrier frequency of the TCC carrier signal between a first frequency transmitted for a first number of cycles and a second frequency transmitted for a second number of cycles; and terminating the TCC beacon signal with an end-of-beacon signature comprising at least one of the first frequency transmitted for a third number of cycles different than the first number of cycles and/or the second frequency transmitted for a fourth number of cycles different than the second number of cycles; generate at least one TCC data signal subsequent to the at least one TCC beacon signal by modulating a second property of the TCC carrier signal different than the first property according to a second type of modulation different than the first type of modulation; and transmit the at least one TCC beacon signal and at least one TCC data signal. 2. The device of claim 1 , wherein the TCC transmitter is configured to: modulate the first property of the TCC carrier signal by modulating the carrier frequency of the TCC carrier signal according to a frequency shift keying (FSK) modulation, and modulate the second property of the TCC carrier signal by modulating a phase of the TCC carrier signal according to a phase shift keying (PSK) modulation. 3. The device of claim 1 , wherein the TCC transmitter is configured to generate the TCC beacon signal by: modulating the carrier frequency of the TCC carrier signal between the first frequency and the second frequency, wherein the first frequency is greater than the carrier frequency of the TCC carrier signal and the second frequency is less than the carrier frequency of the TCC carrier signal. 4. The device of claim 1 , further comprising: a sensing circuit configured to obtain a cardiac electrical signal obtained via a sensing electrode vector; and a control circuit coupled to sensing circuit and the TCC transmitter and configured to: detect a first cardiac event within the cardiac electrical signal, start an allowed transmission window in response to detecting the first cardiac event; and control the TCC transmitter to generate the TCC beacon signal during the allowed transmission window. 5. The device of claim 4 , wherein: the control circuit is configured to: detect a second cardiac event within the cardiac electrical signal following the first cardiac event, and terminate the allowed transmission window in response to detecting the second cardiac event; and the TCC transmitter is configured to: terminate one of the TCC beacon signal and the TCC data signal being transmitted at the termination of the allowed transmission window. 6. The device of claim 5 , further comprising a therapy circuit configured to generate and deliver a cardiac electrical stimulation pulse; wherein the control circuit is configured to detect the second cardiac event in response to the generated electrical stimulation pulse. 7. The device of claim 4 , wherein the control circuit is configured to apply a blanking period to the sensing circuit in response to detecting the first cardiac event; wherein TCC transmitter is configured to start generating the TCC beacon signal during the blanking period. 8. The device of claim 1 , further comprising a TCC receiver configured to receive an acknowledgment signal during a receiving period subsequent to the TCC beacon signal; the TCC transmitter being further configured to: adjust at least one of a TCC beacon signal duration, the receiving period, and/or a beacon control interval in response to the receiving period expiring without the TCC receiver receiving the acknowledgment signal; and control the TCC transmitter to generate a next TCC beacon signal after the beacon control interval in response to the TCC receiver not receiving the acknowledgment signal during the receiving period. 9. The device of claim 1 , wherein the TCC transmitter is further configured to: adjust at least one of a TCC beacon signal duration, an acknowledgment receiving period, and/or a beacon control interval based on a time of day. 10. The device of claim 1 , wherein the TCC transmitter is configured to generate the TCC beacon signal having a first peak-to-peak amplitude that is not modulated during the TCC beacon signal and generate the TCC data signal having a second peak-to-peak amplitude that is not modulated during the TCC data signal, the first peak-to-peak amplitude being greater than the second peak-to-peak amplitude. 11. The device of claim 1 , further comprising: a clock circuit configured to generate a first clock signal having a first clock frequency and generate a second clock signal having a second clock frequency greater than the first clock frequency, wherein the TCC transmitter is configured to: generate the TCC carrier signal at the carrier frequency using the first clock signal for generating the at least one beacon signal; and generate the TCC carrier signal at the carrier frequency using the second clock frequency greater than the first clock frequency for generating the at least one TCC data signal. 12. A method comprising: generating a tissue conduction communication (TCC) carrier signal having a carrier frequency; generating at least one TCC beacon signal by modulating a first property of the TCC carrier signal according to a first type of modulation by modulating the carrier frequency of the TCC carrier signal between a first frequency transmitted for a first number of cycles and a second frequency transmitted for a second number of cycles; and terminating the TCC beacon signal with an end-of-beacon signature comprising at least one of the first frequency transmitted for a third number of cycles different than the first number of cycles and/or the second frequency transmitted for a fourth number of cycles different than the second number of cycles; and generating a TCC data signal subsequent to the TCC beacon signal by modulating a second property of the TCC carrier signal different than the first property according to a second type of modulation different than the first type of modulation. 13. The method of claim 12 , wherein: modulating the first property of the TCC carrier signal comprises modulating the carrier frequency of the TCC carrier signal according to a frequency shift keying (FSK) modulation, and modulating the second property of the TCC carrier signal comprises modulating a phase of the TCC carrier signal according to a phase shift keying (PSK) modulation. 14. The method of claim 12 , wherein generating the TCC beacon signal comprises: modulating the carrier frequency of the TCC carrier signal between the first frequency, wherein the first frequency is greater than the carrier frequency of the TCC carrier signal and the second frequency is less than the carrier frequency of the TCC carrier signal. 15. The method of claim 12 , further comprising: detecting a first cardiac event within a cardiac electrical signal; starting an allowed transmission window by the control circuit in response to detecting the first cardiac event; and controlling the TCC transmitter to generate the TCC beacon signal during the allowed transmission window. 16. The method of claim 15 , further comprising: detecting a second cardiac even
Communication to several implantable medical devices within one patient · CPC title
in combination with another heart therapy · CPC title
controlled by a physiological parameter, e.g. heart potential {(evoked response A61N1/371)} · CPC title
characterised by the communication link, e.g. acoustic or tactile · CPC title
Casings with electrodes thereon, e.g. leadless stimulators · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.